IQVIA, in collaboration with Amazon Web Services (AWS), today announced at the HIMSS conference the availability of its Privacy Analytics Platform on AWS Marketplace. This marks the first privacy-enhancing technology (PET) solution in Europe designed to support European Health Data Space (EHDS) requirements to be offered through a cloud marketplace. The platform enables healthcare organizations, research institutions and EU Member States to access cross-border health data for secondary use, while maintaining robust privacy protections. Organizations can now more easily access and deploy enterprise-grade privacy capabilities at scale, simplifying procurement and accelerating their path to EHDS readiness.
About us
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.
- Website
-
https://www.iqvia.com/
External link for IQVIA
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Durham, North Carolina
- Type
- Public Company
- Specialties
- Technology, Consulting, and Clinical Development
Locations
-
Primary
Get directions
2400 Ellis Rd
Durham, North Carolina 27703, US
Employees at IQVIA
Updates
-
As conversations unfold at ISPOR Philadelphia, explore how innovation in data and evidence is reshaping decision making across healthcare. In case you missed it, IQVIA’s presentations included: Yang (Julian) Xie’s breakout session examined how real world evidence is advancing value assessment approaches and informing access and reimbursement decisions across the United States and China. Lia Pizzicato’s workshop focused on how publicly available data can expand the reach and impact of HEOR research, complementing traditional data sources across global markets. These sessions offered perspective on where the industry is heading and how organizations can translate evolving evidence into meaningful impact. Let’s continue the conversation – reach out to speak with an IQVIA expert.
-
-
Thank you, Gina Smith, for sharing what it’s like to work in pediatric rare disease research. It’s a powerful reminder that behind every study are families holding onto hope, and teams driven by purpose, even when the work is hard. As we approach #ClinicalTrialsDay, what keeps you motivated in this field of work?
-
Career gap on your resume? You're not alone. Ashley Sloan, senior IQVIA recruiter, gives her honest take on how to handle it. See more advice in our latest blog: https://bit.ly/42E1B4v #WeAreIQVIA
-
We’re live at ISPOR 2026! We’re having many conversations about how the industry is approaching patient centered research and evidence generation. These themes were reflected in sessions featuring IQVIA experts: • Karen MacDonald’s panel session explored how integrating clinical outcomes assessments (COAs)and patient preference information (PPI) can better inform decision making across clinical care, regulatory review, and health technology assessment. • Konstantina Skaltsa spoke on a panel about how the estimand framework can facilitate meaningful patient-centered evidence and identify current opportunities and challenges for cancer research. These perspectives highlight a broader move toward more inclusive, evidence driven approaches to healthcare decision making, with more insights to come. Learn more and continue the conversation after the conference.
-
-
The right COA strategy helps trials run smoother and delivers evidence that teams can trust. When endpoints are thoughtfully designed and fit for purpose, sponsors gain clearer insights, fewer surprises, and greater confidence in results. Read our latest blog to learn how thoughtful COA planning turns evidence into insight. https://bit.ly/3Rf8gPY
-
-
If you’ll be attending DIA, let’s lock in time to connect and talk through what matters most to you this year.
DIA can get busy fast, but we don’t want to miss the chance to meet and chat with you. Book time with our team ahead of the event and let’s discuss how we can help you achieve your goals with the right innovation and expertise: https://bit.ly/4mGhNeE
-
-
In a recent study, researchers at a large academic medical center used IQVIA Healthcare‑grade AI® to better identify patients with IgA nephropathy (IgAN) — a serious kidney disease often missed by diagnosis codes alone. ~3x higher risk of end‑stage kidney failure in the Chronic Kidney Disease (CKD) cohort. ~8x higher risk of heart‑failure–related hospitalization in the non CKD cohort. Learn more: https://lnkd.in/dHRV4Khk
-
-
At IQVIA, the CRA role is evolving to become more strategic through three unique career paths. Which one is right for you? Read the blog to find out: https://bit.ly/49TfCPx #WeAreIQVIA
-
-
Nearly all pregnant women need to take medications during pregnancy, so collecting safety data on medication use throughout pregnancy enables a more complete picture of health outcomes. In this new article, IQVIA’s Karin de Haart discusses how integrating data ecosystems, using technology thoughtfully, and collaborating globally can close the evidence gap and help pregnant women make informed decisions for themselves and their child. https://bit.ly/42xdglr
-